INCIDENCE OF HYPERTENSION IN ASTHMA PATIENTS WHO TREATED WITH BETA-2 AGONISTS BRONCHODILATORS

UPT. PERPUSTAKAAN Universitas Esa Unggul Kampus Emas UEU - Jakarta Barat
Phone	:	021-5674223, ext 282
Fax	:
E-mail	:	[email protected]
Website	:	http://library.esaunggul.ac.id
Support (Customer Service) :
[email protected]

Welcome..guys!

Have a problem with your access?
Please, contact our technical support below:

LIVE SUPPORT

Astrid Chrisafi

! ATTENTION !

To facilitate the activation process, please fill out the member application form correctly and completely

Registration activation of our members will process up to max 24 hours (confirm by email). Please wait patiently

Still Confuse?
Please read our User Guide

UEU » Journal » Farmasi
Posted by [email protected] at 15/01/2020 12:30:31 • 525 Views

INCIDENCE OF HYPERTENSION IN ASTHMA PATIENTS WHO TREATED WITH BETA-2 AGONISTS BRONCHODILATORS

Created by :
Dr. APRILITA RINA YANTI EFF, M.Biomed, Apt ( 215020572 )

Subject:	HIPERTENSI ASMA
Alt. Subject :	HYPERTENSION ASTHMA
Keyword:	AGONISTS BRONCHODILATORS

Description:

Objective: To determine the prevalence of hypertension in hospitalized patients with asthma who were treated with beta-2 agonists. To evaluate the correlation between the duration of the use of beta-2 agonist with the incidence of hypertension. Methods: This research is a descriptive epidemiological, observational cross-sectional and retrospective study design. The study population was all adult asthma patients (age ≥ 25) without a concomitant diseases such as hypertension or metabolic syndrome treated with β2 agonists as a bronchodilator and underwent hospitalized in January 2015-December 2015 (n=108). Patient data were collected from the medical record. Data were analyzed using univariate and bivariate to count the number of occurrences of hypertension and recognizing the correlation between the duration of the use of β2 agonists with hypertension event. Results: The incidence of hypertension in patients with asthma who were treated with beta-2 agonists are 50, 93% at the stage of pre-hypertension (120 mm Hg/80 mm Hg) and 25, 9% in stage I hypertension (140 mmHg/90 mmHg). Body weight and duration of therapy with a β2 agonist positively correlated with the incidence of hypertension with a correlation coefficient (r) 0.231 and 0.386 respectively. Conclusion: In this study, duration of therapy with a β2 agonist in asthma patients positively correlated with the incidence of hypertension.

Date Create	:	15/01/2020
Type	:	Text
Format	:	PDF
Language	:	Indonesian
Identifier	:	UEU-Journal-11_0071
Collection ID	:	11_0071

Source :
International Journal of Pharmacy and Pharmaceutical Sciences , Vol. 9, Issue 4, 2017

Relation Collection:
Fakultas Ilmu Kesehatan

Coverage :
Civitas Akademika Universitas Esa Unggul

Rights :
@2020 Perpustakaan Universitas Esa Unggul

Publication URL :
https://digilib.esaunggul.ac.id/incidence-of-hypertension-in-asthma-patients-who-treated-with-beta2-agonists-bronchodilators-14155.html

[ Free Download - Free for All ]